We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.47B
AUM Growth
-$8.91M
Cap. Flow
-$61.4M
Cap. Flow %
-2.48%
Top 10 Hldgs %
64.01%
Holding
148
New
9
Increased
30
Reduced
67
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 23.38%
2 Consumer Discretionary 15.08%
3 Energy 14.69%
4 Industrials 13.22%
5 Financials 12.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXAI
26
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$9.85M 0.4%
1,932,204
-2,014,614
-51% -$9.94M
HTHT icon
27
Huazhu Hotels Group
HTHT
$13B
$9.53M 0.39%
286,153
-2,789
-1% -$105K
FLUT icon
28
Flutter Entertainment
FLUT
$16.4B
$9.31M 0.38%
+51,000
New +$9.81M
V icon
29
Visa
V
$677B
$9.07M 0.37%
34,544
AAPL icon
30
Apple
AAPL
$4.57T
$7.19M 0.29%
+34,133
New +$6.37M
ZTS icon
31
Zoetis
ZTS
$30B
$6.93M 0.28%
40,000
+20,000
+100% +$3.33M
ROIV icon
32
Roivant Sciences
ROIV
$26.2B
$6.02M 0.24%
569,745
-99,302
-15% -$1.09M
BCYC
33
Bicycle Therapeutics
BCYC
$292M
$5.94M 0.24%
293,445
-39,556
-12% -$894K
APGE icon
34
Apogee Therapeutics
APGE
$10.2B
$5.8M 0.23%
147,472
-20,406
-12% -$990K
JNJ icon
35
Johnson & Johnson
JNJ
$625B
$5.25M 0.21%
35,942
-3,871
-10% -$576K
IDYA icon
36
IDEAYA Biosciences
IDYA
$3.56B
$5.08M 0.21%
144,717
-17,837
-11% -$706K
IMVT icon
37
Immunovant
IMVT
$8.25B
$5.08M 0.21%
192,242
+1,586
+0.8% +$45.1K
VERA icon
38
Vera Therapeutics
VERA
$2.36B
$4.94M 0.2%
136,416
-17,516
-11% -$695K
BKNG icon
39
Booking.com
BKNG
$161B
$4.69M 0.19%
29,625
NFLX icon
40
Netflix
NFLX
$309B
$4.49M 0.18%
66,480
CNTA
41
DELISTED
Centessa Pharmaceuticals
CNTA
$4.48M 0.18%
495,895
+10,721
+2% +$102K
MRUS
42
DELISTED
Merus
MRUS
$4.36M 0.18%
73,722
-25,768
-26% -$1.25M
ADCT icon
43
ADC Therapeutics
ADCT
$144M
$4.1M 0.17%
+1,296,153
New +$5.15M
ADBE icon
44
Adobe
ADBE
$105B
$3.99M 0.16%
7,189
-10,579
-60% -$5.12M
MSFT icon
45
Microsoft
MSFT
$3.71T
$3.84M 0.16%
8,589
ACIU icon
46
AC Immune
ACIU
$240M
$3.8M 0.15%
952,069
-142,957
-13% -$473K
CSGP icon
47
CoStar Group
CSGP
$12.3B
$3.71M 0.15%
50,000
QTRX icon
48
Quanterix
QTRX
$190M
$3.67M 0.15%
277,636
+60,194
+28% +$1.01M
GOSS icon
49
Gossamer Bio
GOSS
$87M
$3.18M 0.13%
3,524,908
-1,169,157
-25% -$875K
ZYME icon
50
Zymeworks
ZYME
$1.67B
$3.17M 0.13%
373,002
-45,374
-11% -$404K

Similar funds

Platinum Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Platinum Investment Management held 148 positions worth $2.47B, down 0.36% from $2.48B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Platinum Investment Management's Q2 2024 filing shows 9 new, 30 increased, 67 reduced and 14 closed positions. Its largest new stake was Lamb Weston: 729,393 shares worth $61.3M. The largest sale was Meta Platforms (Facebook), an estimated $48.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Energy.

  • Platinum Investment Management's largest Q2 2024 buy was Lamb Weston: 729,393 shares worth $61.3M.
  • Platinum Investment Management added most to Alphabet (Google) Class A in Q2 2024, an estimated $125M increase.
  • Platinum Investment Management's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $48.7M.
  • Platinum Investment Management fully exited Inhibrx, Inc. Common Stock in Q2 2024, selling an estimated $5.1M.
  • Platinum Investment Management's ten largest holdings make up 64% of its $2.47B portfolio in Q2 2024.
  • Platinum Investment Management opened 9 new positions and closed 14 in Q2 2024.
  • Platinum Investment Management's portfolio value fell 0.36% quarter-over-quarter to $2.47B.

Based on Platinum Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.